Skip to main content

Table 2 Immunoprophylaxis in infants of HBsAg positive mothers in Jiangsu, 2002–2004

From: Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China

 

Total n = 298 (%)

Urban n = 70 (%)

Rural n = 228 (%)

Pvalue

Prenatal HBsAg screening

156 (52.3)

49 (70.0)

107 (46.9)

< 0.001

Use of HBIG for infants

112 (37.6)

39 (55.7)

73 (32.0)

< 0.001

Use of HBV vaccine for infants

298 (100)

70 (100)

228 (100)

 

Timely birth dose

 253 (84.9)

 60 (85.7)

 193 (84.6)

0.828

Fewer than three doses

 21 (7.0)

 3 (4.3)

 18 (7.9)

 

Three doses but not on schedule

 42 (14.1)

 12 (17.1)

 30 (13.2)

 

Three doses on time

 235 (78.9)

 54 (77.1)

 181 (79.4)